Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Shekhter-Levin, S; Gollin, SM; Kaplan, SS; Redner, RL
   Involvement of the MLL and RAR alpha genes in a patient with acute monocytic leukemia with t(11;17)(q23;q12)
   LEUKEMIA
   
   S. Shekhter-Levin et al., "Involvement of the MLL and RAR alpha genes in a patient with acute monocytic leukemia with t(11;17)(q23;q12)", LEUKEMIA, 14(3), 2000, pp. 520-522
2. Redner, RL; Chen, JD; Rush, EA; Li, H; Pollock, SL
   The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties
   BLOOD
   
   R.L. Redner et al., "The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties", BLOOD, 95(8), 2000, pp. 2683-2690
3. Wang, JX; Saunthararajah, Y; Redner, RL; Liu, JM
   Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
   CANCER RESEARCH
   
   J.X. Wang et al., "Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells", CANCER RES, 59(12), 1999, pp. 2766-2769
4. Redner, RL; Wang, JX; Liu, JM
   Chromatin remodeling and leukemia: New therapeutic paradigms
   BLOOD
   
   R.L. Redner et al., "Chromatin remodeling and leukemia: New therapeutic paradigms", BLOOD, 94(2), 1999, pp. 417-428
5. Du, CC; Redner, RL; Cooke, MP; Lavau, C
   Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes
   BLOOD
   
   C.C. Du et al., "Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes", BLOOD, 94(2), 1999, pp. 793-802
6. WANG JX; HOSHINO T; REDNER RL; KAJIGAYA S; LIU JM
   ETO, FUSION PARTNER IN T(8-21) ACUTE MYELOID-LEUKEMIA, REPRESSES TRANSCRIPTION BY INTERACTION WITH THE HUMAN N-COR MSIN3/HDAC1 COMPLEX/
   Proceedings of the National Academy of Sciences of the United Statesof America
   
   J.X. Wang et al., "ETO, FUSION PARTNER IN T(8-21) ACUTE MYELOID-LEUKEMIA, REPRESSES TRANSCRIPTION BY INTERACTION WITH THE HUMAN N-COR MSIN3/HDAC1 COMPLEX/", Proceedings of the National Academy of Sciences of the United Statesof America, 95(18), 1998, pp. 10860-10865
7. REDNER RL; COREY SJ; RUSH EA
   DIFFERENTIATION OF T(5-17) VARIANT ACUTE PROMYELOCYTIC LEUKEMIC BLASTS BY ALL-TRANS-RETINOIC ACID
   Leukemia
   
   R.L. Redner et al., "DIFFERENTIATION OF T(5-17) VARIANT ACUTE PROMYELOCYTIC LEUKEMIC BLASTS BY ALL-TRANS-RETINOIC ACID", Leukemia, 11(7), 1997, pp. 1014-1016
8. GERSZTEN PC; WELCH WC; SPEARMAN MP; JUNGREIS CA; REDNER RL
   ISOLATED DEEP CEREBRAL VENOUS THROMBOSIS TREATED BY DIRECT ENDOVASCULAR THROMBOLYSIS
   Surgical neurology
   
   P.C. Gerszten et al., "ISOLATED DEEP CEREBRAL VENOUS THROMBOSIS TREATED BY DIRECT ENDOVASCULAR THROMBOLYSIS", Surgical neurology, 48(3), 1997, pp. 261-266
9. REDNER RL; RUSH EA; SCHLESINGER KW; POLLOCK SL; WATKINS SC
   THE T(5-17) APL FUSION PROTEIN NPM-RAR DOES NOT ALTER PML LOCALIZATION
   Blood
   
   R.L. Redner et al., "THE T(5-17) APL FUSION PROTEIN NPM-RAR DOES NOT ALTER PML LOCALIZATION", Blood, 90(10), 1997, pp. 1431-1431
10. REDNER RL; COREY SJ; RUSH EA
    ATRA INDUCED-DIFFERENTIATION OF T(5-17) APL BLASTS IN-VITRO
    Blood
    
    R.L. Redner et al., "ATRA INDUCED-DIFFERENTIATION OF T(5-17) APL BLASTS IN-VITRO", Blood, 88(10), 1996, pp. 3328-3328
11. REDNER RL; RUSH EA; POLLOCK SL
    FORCED EXPRESSION OF THE NPM-RAR FUSION GENE INHIBITS DIFFERENTIATIONOF U937 CELLS
    Blood
    
    R.L. Redner et al., "FORCED EXPRESSION OF THE NPM-RAR FUSION GENE INHIBITS DIFFERENTIATIONOF U937 CELLS", Blood, 88(10), 1996, pp. 2192-2192
12. REDNER RL; RUSH EA; FAAS S; RUDERT WA; COREY SJ
    THE T(5-17) VARIANT OF ACUTE PROMYELOCYTIC LEUKEMIA EXPRESSES A NUCLEOPHOSMIN RETINOIC ACID RECEPTOR FUSION
    Blood
    
    R.L. Redner et al., "THE T(5-17) VARIANT OF ACUTE PROMYELOCYTIC LEUKEMIA EXPRESSES A NUCLEOPHOSMIN RETINOIC ACID RECEPTOR FUSION", Blood, 87(3), 1996, pp. 882-886
13. REDNER RL; COREY SJ; RUSH EA
    THE NPM-RAR FUSION PROTEIN ACTS AS A RETINOIC ACID-DEPENDENT TRANSCRIPTIONAL ACTIVATOR
    Blood
    
    R.L. Redner et al., "THE NPM-RAR FUSION PROTEIN ACTS AS A RETINOIC ACID-DEPENDENT TRANSCRIPTIONAL ACTIVATOR", Blood, 86(10), 1995, pp. 135-135
14. COREY SJ; LOCKER J; OLIVERI DR; SHEKHTERLEVIN S; REDNER RL; PENCHANSKY L; GOLLIN SM
    A NONCLASSICAL TRANSLOCATION INVOLVING 17Q12 (RETINOIC ACID RECEPTOR-ALPHA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APML) WITH ATYPICAL FEATURES
    Leukemia
    
    S.J. Corey et al., "A NONCLASSICAL TRANSLOCATION INVOLVING 17Q12 (RETINOIC ACID RECEPTOR-ALPHA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APML) WITH ATYPICAL FEATURES", Leukemia, 8(8), 1994, pp. 1350-1353
15. REDNER RL; RUSH EA; FAAS S; RUDERT WA; COREY SJ
    THE T(517) TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA GENERATES A NUCLEOPHOSMIN-RARA FUSION TRANSCRIPT
    Blood
    
    R.L. Redner et al., "THE T(517) TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA GENERATES A NUCLEOPHOSMIN-RARA FUSION TRANSCRIPT", Blood, 84(10), 1994, pp. 10000375-10000375
16. REDNER RL; RUSH EA
    EXPRESSION OF PML-RAR IN IL-3 DEPENDENT 32D CELLS DOES NOT CONFER FACTOR INDEPENDENCE
    Blood
    
    R.L. Redner e E.A. Rush, "EXPRESSION OF PML-RAR IN IL-3 DEPENDENT 32D CELLS DOES NOT CONFER FACTOR INDEPENDENCE", Blood, 82(10), 1993, pp. 10000532-10000532